VIRT vs VRTX · P/E 13, rev $2.88B vs P/E 30, rev $12.00B
Virtu Financial, Inc. (VIRT) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Virtu Financial, Inc. (VIRT) is a capital markets company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported VIRT revenue for 2024-12-31 was $2.88B. Net income was $534.5M. Revenue was up 25.4% from 2023-12-31 to 2024-12-31. VIRT currently screens at market cap $6.78B and trailing P/E 12.7.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
VIRT currently screens at market cap $6.78B and trailing P/E 12.7. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the VIRT and VRTX stock pages for the full models.
Not investment advice.